Hidrocortizon Atb (Hydrocortisone)

Hidrocortizon Atb is indicated for several endocrine and inflammatory conditions that require systemic glucocorticoid therapy.

• Replacement therapy for primary or secondary adrenal insufficiency.
• Management of acute adrenal crisis.
• Treatment of severe inflammatory disorders such as rheumatoid arthritis, systemic lupus erythematosus, or severe dermatitis.
• Adjunct therapy for allergic reactions that are not controlled by antihistamines.
• Short‑term control of asthma exacerbations when oral steroids are indicated.
• Suppression of autoimmune activity in organ‑specific autoimmune diseases such as autoimmune hepatitis.

• Hydrocortisone is a synthetic analogue of cortisol that acts as an agonist at intracellular glucocorticoid receptors. After oral absorption, the drug diffuses into cells and binds to the receptor complex, translocating to the nucleus where it modulates gene transcription. This results in decreased synthesis of pro‑inflammatory cytokines, inhibition of phospholipase A2, and reduced expression of adhesion molecules, collectively producing anti‑inflammatory and immunosuppressive effects.

Oral hydrocortisone may cause a range of adverse reactions, some of which are dose‑related and reversible, while others can be more serious.

Common

• Increased appetite and weight gain.
• Mild fluid retention (edema).
• Elevated blood glucose, especially in diabetics.
• Mood changes such as irritability.
• Stomach upset or nausea.
• Skin thinning or easy bruising.
• Acne or skin rash.

Serious

• Severe hyperglycemia or new‑onset diabetes.
• High blood pressure or worsening hypertension.
• Adrenal insufficiency after abrupt stop.
• Increased susceptibility to infections.
• Bone loss or fractures with long‑term use.
• Psychiatric disturbances such as depression or psychosis.
• Delayed wound healing.
• These reactions can vary in frequency and severity depending on dose and treatment duration.

When prescribing Hidrocortizon Atb, clinicians should evaluate several precautionary factors to minimize risk and ensure appropriate use.

• Check for active infections, as steroids may worsen them.
• Review blood glucose and blood pressure control before starting.
• Use the lowest effective dose and limit treatment duration.
• Monitor electrolytes and glucose periodically during therapy.
• Assess adrenal function before abrupt discontinuation.
• Use caution in patients with osteoporosis or fracture risk.
• Avoid during pregnancy unless benefits clearly outweigh risks.

Hydrocortisone can interact with other medicines, altering its efficacy or increasing the likelihood of adverse effects.

Avoid

• Strong CYP3A4 inducers such as rifampin, which may reduce hydrocortisone levels.
• High‑dose systemic steroids combined with other glucocorticoids, increasing risk of systemic toxicity.

Use with caution

• Antidiabetic agents; hydrocortisone may raise blood glucose, requiring dose adjustments.
• Antihypertensive drugs; fluid retention can blunt blood pressure control.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs); combined use may increase risk of gastrointestinal ulceration.
• Anticoagulants; steroids can affect platelet function and clotting parameters.